Skip to content
Veranex - Transforming Your MedTech Innovation
  • News
  • Events
  • Resources
  • Careers
  • Blog
    • MedTech Pioneers
    • Veranex Blog
  • Industry Expertise
    • Medical Devices
    • Clinical Diagnostics & Life Sciences
    • Drug Delivery Systems and Biopharmaceuticals
    • Information Technology and Digital Health
  • Services
    • End-to-End Services
      • Product Design & Engineering
        • Human Factors and Usability Testing
      • Preclinical Services
        • Pathology
      • Clinical Development Services
      • Data Management & Analytics
        • Statistical Programming and Biostatistics
        • Risk Based & Central Monitoring (RBM)
        • Data Visualization
        • Medical Writing and Publishing
        • Pharmacovigilance and Postmarket Surveillance
        • Functional Outsourcing/Full-Service Resourcing
        • Clinical Data Management
      • Regulatory Affairs & Quality Management
      • Commercial Strategy & Market Access
  • Solutions
    • Medical Device Solutions
    • End-to-End Integrated Development
    • Clinical Area & Technology Expertise
    • Functional Service Provider
    • Start-up Solutions
  • About
    • About Veranex
    • Leadership Team
  • Contact
May 13, 2022

Rezolute Optimizes Efficiency and Control With FSP Outsourcing

May 13, 2022

May 13, 2022

Data Management, SAS, and Rave Resources Drive Scalability

May 13, 2022

May 13, 2022

Partnership Empowers Catawba to Reduce TCO for Clients

May 13, 2022

May 13, 2022

Partnership Gives Midsize CRO a Competitive Edge

May 13, 2022

May 13, 2022

Veranex Helps Top 10 Generics Sponsor File First

May 13, 2022

May 13, 2022

Data Management and FSP Services Shave Weeks Off Startup Time

May 13, 2022

May 13, 2022

Data Expertise Rescues Study by a Top 3 Generics CRO

May 13, 2022

May 6, 2022

U.S. Market Access and Commercialization Planning for Novel Genomic Test

Veranex_BHA_Overview_CS-Graphics_4-14-22_VF_Advanced-Diagnostics-02-1

May 6, 2022

April 26, 2022

LEXAGENE MIQLAB™

lexagene

April 26, 2022

April 26, 2022

GENTURA Partners With Veranex to Make Molecular Diagnostics More Accessible

gentura

April 26, 2022

Posts navigation

Older posts

Ready to Start Your Innovation Journey?

Let's Get Started

© 2023 Veranex. All Rights Reserved.

  • Privacy Policy
  • Industry Expertise
    • Medical Devices
    • Clinical Diagnostics & Life Sciences
    • Drug Delivery Systems and Biopharmaceuticals
    • Information Technology and Digital Health
  • Services
    • End-to-End Services
      • Product Design & Engineering
        • Human Factors and Usability Testing
      • Preclinical Services
        • Pathology
      • Clinical Development Services
      • Data Management & Analytics
        • Statistical Programming and Biostatistics
        • Risk Based & Central Monitoring (RBM)
        • Data Visualization
        • Medical Writing and Publishing
        • Pharmacovigilance and Postmarket Surveillance
        • Functional Outsourcing/Full-Service Resourcing
        • Clinical Data Management
      • Regulatory Affairs & Quality Management
      • Commercial Strategy & Market Access
  • Solutions
    • Medical Device Solutions
    • End-to-End Integrated Development
    • Clinical Area & Technology Expertise
    • Functional Service Provider
    • Start-up Solutions
  • About
    • About Veranex
    • Leadership Team
  • Contact
  • News
  • Events
  • Resources
  • Careers
  • Blog
    • MedTech Pioneers
    • Veranex Blog